New Medicare Prior Authorization Requirements for DMEPOS: What Changes on October 28, 2026?

If your organization supplies Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) to Medicare beneficiaries, October 28, 2026 is an important date to review.

CMS announced that 20 HCPCS codes will be added to the DMEPOS Master List effective October 28, 2026, and eight HCPCS codes have been selected for required prior authorization. Six of those eight will begin required prior authorization nationwide on October 28, while two upper-limb orthosis codes will follow a phased rollout.

For DMEPOS organizations, however, the real question isn’t simply:

“What did CMS change?”

It is:

“Do we supply any of the affected items—and what needs to happen before the next eligible item is delivered?”

Which DMEPOS Items Are Affected on October 28?

CMS has selected six codes for nationwide required prior authorization beginning October 28, 2026:

CMS has also selected two upper-limb orthosis codes, L3761 and L3916, for phased implementation.

For those two codes:

Phase 1 — October 28, 2026: California, Florida, Michigan, and New York

Phase 2 — January 26, 2027: Phase 1 states plus Arizona, Georgia, Illinois, Massachusetts, Ohio, Oregon, Pennsylvania, and Texas

Phase 3 — April 26, 2027: Nationwide.

This is why DMEPOS organizations need to look beyond the announcement itself. Product category, HCPCS code, location, and effective date can all matter when determining whether the new requirement applies.

Master List Doesn’t Automatically Mean Prior Authorization

This is an important distinction for DMEPOS suppliers reviewing their product portfolios.

CMS says that as of October 28, 2026, the Master List will contain 550 items, the Required Prior Authorization List will contain 82 items, and the Required Face-to-Face Encounter and Written Order Prior to Delivery List will contain 105 items.

But appearing on the Master List alone does not mean a supplier needs to take action.

CMS specifically states that providers and suppliers don’t need to act unless the item also appears on one or both Required Lists.

So instead of asking only:

“Is this HCPCS code on the Master List?”

DMEPOS organizations should ask:

“Which Medicare requirement applies to this item?”

How Could This Affect DMEPOS

Providers, Suppliers, and U.S. Healthcare?

CMS describes prior authorization as a process that helps DMEPOS suppliers ensure applicable Medicare coverage, payment, and coding rules are met before DMEPOS items are delivered. CMS also says the program is intended to protect the Medicare Trust Fund from improper payments while helping beneficiaries receive needed DMEPOS items in a timely manner.

For affected DMEPOS organizations, this creates several practical considerations.

1.  The Requirement Needs to Be Identified Before Delivery

For the newly selected items, CMS says prior authorization becomes a condition of payment according to the applicable implementation date.

That shifts an important question earlier in the workflow. Not just:

“Is the claim ready to submit?”

But:

“What Medicare requirements apply before we deliver this item?”

For organizations supplying wheelchairs, support surfaces, orthoses, prosthetics, or other DMEPOS categories, identifying the applicable requirement at the item level becomes important.

2.  Documentation and Authorization Need to Connect

Prior authorization isn’t the only requirement DMEPOS organizations may need to consider.

CMS maintains a separate list for items subject to face-to-face encounter and written order prior to delivery requirements. CMS also specifies standardized elements for DMEPOS written orders and requires suppliers to retain applicable written orders and supporting documentation.

For affected organizations, a practical workflow review therefore extends beyond billing:

Order → Documentation → Prior Authorization → Delivery → Billing

The exact requirements depend on the specific DMEPOS item and applicable Medicare rules.

3.  Multi-State DMEPOS Suppliers Need to Watch the Rollout

For L3761 and L3916, the October 28 requirement begins in only four states before expanding in January and April 2027.

A DMEPOS supplier operating across several states therefore needs to know which item is being supplied, where it is being supplied, and whether the applicable implementation phase has begun.

4.  Beneficiary Access Is Part of the Picture

CMS says the prior authorization program is intended both to address improper Medicare payments and to ensure beneficiaries can receive needed DMEPOS items in a timely manner.

That makes the October update relevant beyond billing alone: it connects Medicare requirements, supplier operations, and beneficiary access to covered DMEPOS items.

What About DMEPOS Manufacturers and Distributors?

The CMS requirements are framed around Medicare providers and suppliers. A company does not automatically become responsible for Medicare prior authorization simply because it manufactures an affected product.

However, manufacturers or distributors that also operate as Medicare-enrolled DMEPOS suppliers should review the requirements that apply to their supplier activities.

This distinction is important because the October update covers different DMEPOS categories—not simply traditional durable medical equipment.

5 Questions DMEPOS Organizations Should Ask Before October 28

The update gives affected organizations a useful reason to review their processes now:

1. Do we supply any of the newly selected HCPCS codes?
2. If we handle L3761 or L3916, which implementation phase applies to us?
3. Does our staff understand the difference between the Master List and the Required Lists?
4. Are applicable authorization, order, and documentation requirements identified before delivery?
5. Does the information collected before delivery carry accurately into billing and follow-up?

These questions move the conversation from simply knowing about the CMS update to determining whether the organization is operationally prepared for it.

Another October DMEPOS Update to Know

October 28 isn’t the only relevant date.

CMS is implementing a separate one-year nationwide probationary prior authorization process beginning October 15, 2026, for newly enrolled DMEPOS suppliers and suppliers undergoing a change of ownership. For covered items under that process, CMS will require prior authorization as a condition of payment for dates of service on or after October 15.

This is separate from the October 28 expansion of the Required Prior Authorization List.

Where Reenix Excellence Fits?

For a DMEPOS organization, prior authorization is only one part of the revenue-cycle process.

Orders and documentation can connect with eligibility, authorization, delivery, claim submission, payer follow-up, denials, payment posting, and A/R.

Reenix Excellence supports U.S. DMEPOS providers and suppliers with services including:

• DMEPOS medical billing
• Prior authorization support
• Eligibility verification
• Claim submission and follow-up
• Denial management
• A/R follow-up
• Payment posting
• Revenue cycle management

The CMS update does not mean every DMEPOS organization needs to outsource these functions, and outsourcing does not guarantee Medicare payment.

But if the October changes raise questions about how authorization, documentation, delivery, and billing connect within your organization, this is a relevant time to review the workflow.

Do You Supply Any of the DMEPOS Items Affected on October 28?

Don’t wait until an affected item reaches billing to determine whether something was required earlier in the process.

Request a Complimentary DMEPOS Prior Authorization & Billing Workflow Assessment

Reenix Excellence can review your existing authorization and billing workflow and identify areas that may require closer attention as the new Medicare requirements begin.

FAQs

1. Does every DMEPOS item on the CMS Master List require prior authorization?

No. CMS states that inclusion on the Master List alone doesn’t require providers or suppliers to take action. The item must also appear on one or both Required Lists for the corresponding requirement to apply.

2. Which DMEPOS codes are affected by the October 28 prior authorization expansion?

CMS selected L0456, L0457, L0486, L1833, E0194, and K0005 for nationwide implementation beginning October 28, 2026. L3761 and L3916 begin phased implementation on the same date.

3. Does the October 28 update apply only to durable medical equipment?

No. The newly selected codes span multiple DMEPOS categories, including orthoses, a pressure-reducing support surface, and a manual wheelchair base. DMEPOS itself refers to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies.

References

1. CMS — Prior Authorization Process for Certain DMEPOS Items
2. CMS — Master List of DMEPOS Items Potentially Subject to Conditions of Payment
3. CMS — DMEPOS Order and Face-to-Face Encounter Requirements
4. CMS MLN Connects — September 10, 2026: DMEPOS Probationary Prior Authorization Starts October 15